Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20184153 | 0.82 | OAT (0.44) | CES2 | |
| SCHEMBL15468834 | 0.66 | — | — | |
| SCHEMBL25266843 | 0.61 | GABRR1 (0.33) | FFAR1 | |
| SCHEMBL4883443 | 0.61 | HDAC2 (0.50) | FFAR1 | |
| SCHEMBL812017 | 0.61 | — | — | |
| SCHEMBL14010784 | 0.61 | FFAR1 (0.33) | CES2FFAR1 | |
| SCHEMBL12231391 | 0.60 | — | — | |
| SCHEMBL18356004 | 0.60 | — | — | |
| SCHEMBL17193799 | 0.60 | — | — | |
| SCHEMBL14944456 | 0.60 | FFAR1 (0.32) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159426-A1 | LILY OF THE VALLEY ODORANT | FIRMENICH & CIE (CH) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159426-A1 | LILY OF THE VALLEY ODORANT | ACLY, PIR, NOX5 | CES2 1100/4885FFAR1 1802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.